We partnered with Suven Pharma to sharpen its identity and establish it as a forward-looking Contract Development and Manufacturing Organization (CDMO).
Our engagement began with extensive stakeholder interactions to map Suven’s core competencies, understand its long-term growth plans, and align the brand narrative with its future mergers and acquisitions strategy. This became especially significant after Advent International, a global private equity firm, acquired a 50.1% stake in Suven Pharmaceuticals from the Jasti family in December 2022 for ₹6,313 crore—marking a new chapter of global expansion and strategic growth.
Our Scope
- Brand Identity – Crafted a refreshed logo, digital branding assets, and market positioning
- Content Development – Developed a comprehensive corporate dossier and brand-aligned communication materials
- Corporate Storytelling – Produced a high-impact corporate video, featuring leadership interviews and stakeholder narratives
- Digital Strategy – Designed a social media communication framework to build credibility and enhance global visibility
The Outcome
A cohesive, future-ready brand presence that communicates Suven Pharma’s strengths, ambitions, and growth trajectory—positioning it as a trusted global partner in the pharmaceutical CDMO space.
Client Impact
- Strengthened investor and stakeholder confidence
- Enhanced global visibility and credibility
- Improved partner engagement through cohesive brand storytelling
